DOHA: The National Center for Cancer Care and Research (NCCCR), a member of Hamad Medical Corporation (HMC) hosted an international workshop for cancer clinicians and researchers recently.
This workshop was an important step in developing closer cooperation between clinicians and researchers across clinical and academic institutions throughout Qatar and international organisations.
The main topic was tumour immunology with a focus on the top three cancer diagnosis – Breast Ca, colorectal ca and Leukaemia.
Many current basic cancer research projects were presented by both HMC and research teams in Qatar, thus highlighting the local research activity related to tumour immunology.
Dr Hanadi El Ayoubi, Medical Director at NCCCR and lead organizer of the workshop, said: “This workshop aimed to highlight many of these efforts and review how we can work together more effectively to bring about better care for our patients. We look forward to arranging similar workshops in the future and invite anyone interested in cancer research to contact us.”
Cancer is the third leading cause of death in Qatar, and the top five cancer types here are, breast, colorectal, Leukemia, lymphoma and lung.
The National Cancer Strategy mandates a comprehensive approach to providing advanced research-based treatment options for patients.
A strategic focus for clinicians and researchers is on prevention, early detection, timely intervention and cure of cancer.
The Peninsula
